Study of the Immediate Cardiovascular Effects of Electronic Cigarette in Subjects With Cardiovascular Disease
ECLOPE
Pilot Study of the Immediate Cardiovascular Effects of Electronic Cigarette in Subjects With Cardiovascular Disease
1 other identifier
interventional
5
1 country
1
Brief Summary
Justification Smoking is a major factor for mortality and cardiovascular morbidity. The electronic cigarette, sometimes presented as smoking cessation "classic" is expanding but its safety has not been established to date. The smoke from the electronic cigarette is mainly composed of propylene glycol, some adverse effects were observed in animals. Study Type interventional study assessing the effect of the electronic cigarette Inclusion criteria Topics under 35 years presenting to Rhythm of the consultation for a cardiovascular evaluation and already smoking the electronic cigarette and that for at least 1 month Exclusion criteria
- Consumption of traditional cigarettes, nicotine replacement or toxic
- Presence of heart disease Primary objective To evaluate in a pilot study the immediate cardiovascular effects of electronic cigarette consumption Number of patients 20 Duration of Study Recruitment in 2015 for an unlimited period of inclusion. Exam time is about two hours. Procedures performed during the study Physical examination, ECG, Holter-ECG 10 minutes and echocardiography were performed before and 15 minutes after the consumption of the usual electronic cigarette of the subject. No additional follow-up visit is required
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable cardiovascular-diseases
Started Oct 2015
Shorter than P25 for not_applicable cardiovascular-diseases
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 30, 2015
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 5, 2015
CompletedFirst Submitted
Initial submission to the registry
May 9, 2016
CompletedFirst Posted
Study publicly available on registry
May 19, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2016
CompletedMay 30, 2018
May 1, 2018
1 month
May 9, 2016
May 25, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Assessment of change of blood pressure
before smoking then 15 min after smoking
Assessment of change of Electrocardiogram (ECG)
before smoking then 15 min after smoking
Assessment of change of Holter-ECG
before smoking then 15 min after smoking
Assessment of change of transthoracic echocardiogram
before smoking then 15 min after smoking
Study Arms (1)
Patients using electronic cigarette
OTHERThe patients under the age of 35 followed at the consultation of rythmology for a cardiovascular assessment and already smoking the electronic cigarette and this since at least 1 month. The patient will receive a clinical examination, an electrocardiogram, a Holter-ECG and an echocardiogram before and after electronic cigarette consumption for 15 minutes.
Interventions
Assesment of patients, using electronic cigarette, presenting to the Rhythm of consultation for a cardiovascular evaluation by: 1. A compendium of history, a general physical examination (weight, height) and cardiovascular with measurement of oxygen saturation, an assessment of past and current smoking (with documentation of the concentration of nicotine in the electronic cigarette and the product brand used) 2. measurement of blood pressure 3. An electrocardiogram 4. A Holter-ECG 10 minutes 5. A transthoracic echocardiogram
Eligibility Criteria
You may qualify if:
- Aged under 35 years
- Having no known heart disease
- Not consuming any toxic
- Already smoking the electronic cigarette and that for at least one month to ensure good tolerance of the electronic cigarette
You may not qualify if:
- Subjects also smoking a conventional cigarette or using other nicotine substitutes will be excluded
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Groupe Hospitalier Paris Saint Joseph
Paris, Île-de-France Region, 75014, France
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ghassan MOUBARAK, MD
Groupe Hospitalier Paris Saint-Joseph (FRANCE)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- OTHER
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 9, 2016
First Posted
May 19, 2016
Study Start
October 30, 2015
Primary Completion
December 5, 2015
Study Completion
June 1, 2016
Last Updated
May 30, 2018
Record last verified: 2018-05